Navigation Links
New anti-inflammatory drugs pinch off reactive oxygen species at the source
Date:6/21/2012

Scientists at Emory University School of Medicine have identified a new type of anti-inflammatory compound that may be useful in treating a wide range of conditions, including neurodegenerative and autoimmune diseases. These compounds inhibit the enzyme Nox2, part of a family of enzymes responsible for producing reactive oxygen species (ROS).

The results were published Thursday in the journal Chemistry & Biology.

"Nox2 inhibitors could be valuable with many conditions where inflammation plays a role," says senior author David Lambeth, MD, PhD, professor of pathology and laboratory medicine at Emory University School of Medicine.

ROS and the Nox enzymes play vital roles in the immune and cardiovascular systems, but too much ROS leads to oxidative stress, linked with tissue damage and conditions such as stroke, heart failure and neurodegenerative diseases.

Antioxidants are supposed to absorb ROS, but many clinical studies examining antioxidants' benefits have been disappointing. Compounds that inhibit the Nox enzymes would stop ROS production at the source, rather than mop them up like antioxidants do.

"We are taking a completely different approach," says first author Susan Smith, PhD, Emory research assistant professor of pathology and laboratory medicine. "If a burst pipe is gushing water all over the basement, the first thing you need is a wrench to stop the water from flowing, instead of a mop."

The Nox inhibitors that were already available to researchers are not specific enough for one enzyme over another. Smith collaborated with research scientist Jaeki Min and colleagues at the Emory Chemical Biology Discovery Center and Emory Institute for Drug Development to screen for compounds that inhibit Nox2. In particular, they searched for compounds that interfere with assembly of the Nox2 enzyme rather than targeting the catalytic site.

The screen for compounds that inhibit Nox2 led to the i
'/>"/>

Contact: Quinn Eastman
404-727-7829
Emory University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Not taking gastroprotective drugs prescribed with anti-inflammatory medicines
2. Trivedi Beef, LLC Announces Breakthrough Beef Industry Data without the use of Antibiotic Drugs, Hormones or Steroids
3. New drugs, new ways to target androgens in prostate cancer therapy
4. More Mental Health Woes in College Kids Who Abuse Prescription Drugs
5. American Kids Getting Fewer Prescription Drugs: Study
6. Depressed Teens Who Respond to Treatment Less Likely to Abuse Drugs
7. Doubling down on heart failure: Researchers discover new route to disease, and drugs to match
8. New federal disclosure law may have little impact on drugs prescribed
9. More Research Points to Long-Term Ills With Bone Drugs
10. New inflammation hormone link may pave way to study new drugs for Type 2 diabetes
11. Common Blood Pressure Drugs May Not Cut Colon Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... strongly associated with Alzheimer,s disease; however, researchers are still ... causal agent of the onset and development of the ... beta-amyloid is not harmful when found in isolation but ... to form the so-called amyloid fibrils , "We are ... with multiple ones because each aggregate of peptide, which ...
(Date:10/1/2014)... October 1, 2014 Patients with increased inflammation, ... a greatly increased risk of depression. For example, ... chronic hepatitis C virus infection causes depression in ... acids, more commonly known as fish oil, have ... the risk of heart disease and reducing triglyceride ...
(Date:10/1/2014)... 01, 2014 Insuranceragents.info has released ... good life insurance plan for vulnerable family members. , ... family members. Providers in the family should always carry ... financial hardships for the rest of the family. ... Families can benefit more from temporary coverage or from ...
(Date:10/1/2014)... ATLANTA (PRWEB) October 01, 2014 ... executive networking and relationship-marketing firm, announced today ... Security Executive® and Project of the Year ... decision makers representing organizations in financial services, ... include large-scale technology endeavors that address key ...
(Date:10/1/2014)... 01, 2014 Between 23 million and ... U.S., according to figures from the National Institutes of ... (AARDA), and many of them have something else in ... undiagnosed celiac disease. Gluten Free Therapeutics, makers of ... undiagnosed celiac disease by publishing a series of blog ...
Breaking Medicine News(10 mins):Health News:Laying siege to beta-amyloid, the key protein in Alzheimer's disease 2Health News:Omega-3 fatty acids may prevent some forms of depression 2Health News:Life Insurance for Families - Clients Can Compare Affordable Rates Online! 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 3Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 4Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 5Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 6Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 7Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3
... announced a pre-approval program to compliment the Small Business Administration,s recent ... remove fees charged to banks and make it easier for entrepreneurs ... ... St. Louis, MO (PRWEB) April 7, 2009 -- Health Career ...
... April 7 Leading Sucralose manufacturer Guangdong Food ... announced that the U.S. International Trade Commission (ITC) ... a Section 337 patent dispute (docket no. 337-TA-604) ... & Lyle Corporation (T&L). Mr. Wang Sanyong, ...
... Acupuncture cannot be shown to have any positive effect on ... a systematic review of literature by three groups in Daejon, ... edition of the peer-reviewed journal Climacteric . , Many ... use, but still have to deal with the symptoms which ...
... of corporate training software and solutions, has partnered with Medcom ... courses to CERTPOINTVLS™ users. , ... ... provider of corporate training software and solutions, today announced they ...
... Inc., a global provider of image management services for biopharmaceutical and ... an agreement with AG Mednet, a HIPAA and 21 CFR Part ... to offer clinical trial sponsors more options for efficient, cost-effective image ... ...
... software to an assisted medical billing process providing the medical ... ... (Vocus) April 7, 2009 -- Glenwood Systems LLC announced today the ... efficiencies and improve physician revenue in an office based medical practice. ...
Cached Medicine News:Health News:Health Career Agents Announces SBA Pre-Approval Program to Launch a Healthcare Recruiting Business 2Health News:Health Career Agents Announces SBA Pre-Approval Program to Launch a Healthcare Recruiting Business 3Health News:GDFII/L&P Sucralose Win Over Competitor Tate & Lyle 2Health News:GDFII/L&P Sucralose Win Over Competitor Tate & Lyle 3Health News:Acupuncture 'probably ineffective' in treatment of hot flushes 2Health News:CERTPOINT Systems Partners with Medcom Trainex, Inc. to Offer Extensive Library of Healthcare Courses -- Professionals in Healthcare sector to benefit from online educational courses 2Health News:CERTPOINT Systems Partners with Medcom Trainex, Inc. to Offer Extensive Library of Healthcare Courses -- Professionals in Healthcare sector to benefit from online educational courses 3Health News:CERTPOINT Systems Partners with Medcom Trainex, Inc. to Offer Extensive Library of Healthcare Courses -- Professionals in Healthcare sector to benefit from online educational courses 4Health News:M2S Announces Agreement with AG Mednet to Provide Clinical Trial Sponsors with More Options for Efficient Image Transfer and Collection 2Health News:M2S Announces Agreement with AG Mednet to Provide Clinical Trial Sponsors with More Options for Efficient Image Transfer and Collection 3Health News:Glenwood Systems, LLC Releases EMR Practice Management and Medical Billing Process Improvement Program 2Health News:Glenwood Systems, LLC Releases EMR Practice Management and Medical Billing Process Improvement Program 3
(Date:10/1/2014)... , Oct. 1, 2014 ... now available. Interested parties can learn about ... Cardinal Health is supporting the health care ... http://cardinalhealth.com/annualreport . Photo- http://photos.prnewswire.com/prnh/20140930/149504-INFO ... summary financials and the chief executive officer,s ...
(Date:10/1/2014)... , Oct. 1, 2014  Dyadic International, ... with patented and proprietary technology used to develop ... bioenergy, bio-based chemicals, biopharmaceuticals, and industrial enzymes industries, ... payment from Abengoa Bioenergy for commercial scale production ... biomass into ethanol, developed under Abengoa,s license agreement ...
(Date:10/1/2014)... , Oct. 1, 2014  ResMed (NYSE: ... and the first company to design complete sleep apnea solutions ... women about the importance of a good night,s sleep. ... challenge the myth that feeling tired is just part of ... that sleep is a critical pillar of health, essential to ...
Breaking Medicine Technology:Cardinal Health 2014 Digital Report to Shareholders Now Available 2Dyadic International Reports Licensing Payment For Commercial-Scale Production Of C1-Based Cellulase Enzymes 2Dyadic International Reports Licensing Payment For Commercial-Scale Production Of C1-Based Cellulase Enzymes 3ResMed Launches Initiative to Help Women Get Better Sleep 2ResMed Launches Initiative to Help Women Get Better Sleep 3
... LONDON, Nov. 11, 2010 UK based Trimega Laboratories is ... met the standards set by the prestigious Investors in People ... by the Employer Representative Quality Board of IIP and reflects ... an organization. A significant aspect of the achievement is that, ...
... Inc. (OTCQB: ILIU) today announced financial and operational results for ... for the three months ended September 30, 2010 was $0.5 ... the prior year. The increase was primarily attributable to greater ... Research and development expenses were $0.4 million for the three ...
Cached Medicine Technology:IIP Recognition for Substance Abuse Testing Lab Trimega Laboratories 2Interleukin Genetics Reports Third Quarter 2010 Financial Results 2Interleukin Genetics Reports Third Quarter 2010 Financial Results 3Interleukin Genetics Reports Third Quarter 2010 Financial Results 4Interleukin Genetics Reports Third Quarter 2010 Financial Results 5
Two point fixation, tips separated by 13 mm. Each tip has 0.12 mm, 1 x 2 teeth. Wide serrated handle with thumb catch lock and dull finish....
Magnetic Farnsworth D15 kit Magnets move the color disks. Protects disks from fingerprints. Keeps all the disks in one place. Clear glass insures accurate color perception. Makes color testing fun....
... the Farnsworth-Munsell 100 Hue Test. It is intended ... study of a color vision defect. It provides ... difficulty in distinguishing color differences in certain tasks. ... reference caps with Munsell notations, plus a neutral ...
Spanish HRR/Amsler combination with Spanish and English directions for both HRR and amsler tests plus occluding glasses....
Medicine Products: